Cargando…
Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189911/ https://www.ncbi.nlm.nih.gov/pubmed/33420394 http://dx.doi.org/10.1038/s41409-020-01193-7 |
_version_ | 1783705582041038848 |
---|---|
author | Wei, Na Wang, Yini Wang, Jingshi Wu, Lin Wang, Zhao |
author_facet | Wei, Na Wang, Yini Wang, Jingshi Wu, Lin Wang, Zhao |
author_sort | Wei, Na |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8189911 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-81899112021-06-25 Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab Wei, Na Wang, Yini Wang, Jingshi Wu, Lin Wang, Zhao Bone Marrow Transplant Correspondence Nature Publishing Group UK 2021-01-08 2021 /pmc/articles/PMC8189911/ /pubmed/33420394 http://dx.doi.org/10.1038/s41409-020-01193-7 Text en © The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Wei, Na Wang, Yini Wang, Jingshi Wu, Lin Wang, Zhao Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab |
title | Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab |
title_full | Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab |
title_fullStr | Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab |
title_full_unstemmed | Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab |
title_short | Characteristics of Epstein–Barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active Epstein–Barr virus disease: favorable responses to rituximab |
title_sort | characteristics of epstein–barr virus reactivation after allogeneic haematopoietic stem cell transplantation in patients with chronic active epstein–barr virus disease: favorable responses to rituximab |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8189911/ https://www.ncbi.nlm.nih.gov/pubmed/33420394 http://dx.doi.org/10.1038/s41409-020-01193-7 |
work_keys_str_mv | AT weina characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab AT wangyini characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab AT wangjingshi characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab AT wulin characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab AT wangzhao characteristicsofepsteinbarrvirusreactivationafterallogeneichaematopoieticstemcelltransplantationinpatientswithchronicactiveepsteinbarrvirusdiseasefavorableresponsestorituximab |